Alan Stuart Coates
Impact in
- Cancer Research top 0.02%
- Breast Cancer Treatment Studies
- Oncology top 0.05%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Risks and Factors
- Cancer survivorship and care
Papers in
- Cancer Research 122
- Breast Cancer Treatment Studies 117
- Oncology 126
- Cancer Treatment and Pharmacology 29
- Cancer survivorship and care 29
- HER2/EGFR in Cancer Research 23
- Global Cancer Incidence and Screening 15
- Co-authors
- Richard D. Gelber (119 shared papers)Aron Goldhirsch (115 shared papers)Beat J. K. Thurlimann (59 shared papers)Hans-Jörg Senn (8 shared papers)W. C. Wood (3 shared papers)Karen N. Price (71 shared papers)Monica Castiglione‐Gertsch (72 shared papers)John H. Glick (6 shared papers)
- Journals
- Journal of Clinical Oncology (61 papers)Annals of Oncology (47 papers)Breast Cancer Research and Treatment (20 papers)The Medical Journal of Australia (14 papers)The Breast (13 papers)
- Partner nations
- AustraliaSwitzerlandItaly
In The Last Decade
Alan Stuart Coates
321 papers receiving 37.0k citations
Alan Stuart Coates's Hit Papers
Peers
Comparison fields: 5 of 181
- Cancer Research 16.1k
- Oncology 15.4k
- Genetics 5.7k
- Pathology and Forensic Medicine 3.3k
- Pulmonary and Respiratory Medicine 5.0k
Countries citing papers authored by Alan Stuart Coates
This map shows the geographic impact of Alan Stuart Coates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Stuart Coates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Stuart Coates more than expected).
Fields of papers citing papers by Alan Stuart Coates
This network shows the impact of papers produced by Alan Stuart Coates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Stuart Coates. The network helps show where Alan Stuart Coates may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan Stuart Coates, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 330 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 Hit paper breakdown → | 2011 | 3090 |
| 2 | Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 Hit paper breakdown → | 2013 | 2950 |
| 3 | Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 Hit paper breakdown → | 2015 | 1467 |
| 4 | A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer Hit paper breakdown → | 2004 | 1464 |
| 5 | Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009 Hit paper breakdown → | 2009 | 1136 |
| 6 | Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial Hit paper breakdown → | 2013 | 950 |
| 7 | Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005 Hit paper breakdown → | 2005 | 942 |
| 8 | On the receiving end—patient perception of the side-effects of cancer chemotherapy Hit paper breakdown → | 1983 | 845 |
| 9 | Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials Hit paper breakdown → | 2017 | 844 |
| 10 | Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98 Hit paper breakdown → | 2007 | 746 |
| 11 | Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007 Hit paper breakdown → | 2007 | 745 |
| 12 | Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen Hit paper breakdown → | 2009 | 652 |
| 13 | 2003 | 582 | |
| 14 | Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer Hit paper breakdown → | 2014 | 580 |
| 15 | Adjuvant Ovarian Suppression in Premenopausal Breast Cancer Hit paper breakdown → | 2014 | 560 |
| 16 | 2001 | 506 | |
| 17 | Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer Hit paper breakdown → | 2018 | 496 |
| 18 | Improving the Quality of Life during Chemotherapy for Advanced Breast Cancer Hit paper breakdown → | 1987 | 470 |
| 19 | 2016 | 440 | |
| 20 | 2018 | 401 |
About Alan Stuart Coates
Alan Stuart Coates is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Genetics and Pathology and Forensic Medicine, having authored 330 papers that have together received 38.6k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (117 papers), Estrogen and related hormone effects (40 papers), Cancer Treatment and Pharmacology (29 papers), Cancer survivorship and care (29 papers), HER2/EGFR in Cancer Research (23 papers), Health Systems, Economic Evaluations, Quality of Life (22 papers), Advanced Breast Cancer Therapies (21 papers) and Global Cancer Incidence and Screening (15 papers). The work is most often cited by research in Cancer Research (16.1k citations), Oncology (15.4k citations), Genetics (5.7k citations), Pathology and Forensic Medicine (3.3k citations) and Pulmonary and Respiratory Medicine (5.0k citations). Alan Stuart Coates has collaborated with scholars based in Australia, Switzerland and Italy. Frequent co-authors include Richard D. Gelber, Aron Goldhirsch, Beat J. K. Thurlimann, Hans-Jörg Senn, W. C. Wood, Karen N. Price, Monica Castiglione‐Gertsch, John H. Glick, Marco Angelo Colleoni and John Forbes. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Breast Cancer Research and Treatment, The Medical Journal of Australia and The Breast.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.